false--06-27Q220200000743316falseLarge Accelerated Filerfalse0.0310.0310.0340.0340.0210.0210.0310.03114800072300000000.03450.033750.0250.03450.0337500.460.920.480.961800037000200004200096000310000117000480002010002280003000170000.3270.3270.3130.3130.1960.1960.2840.2840.0260.0260.0270.0270.0160.0160.0160.016
0000743316
2019-06-30
2019-12-28
0000743316
2020-01-17
0000743316
2019-06-29
0000743316
2019-12-28
0000743316
2018-09-30
2018-12-29
0000743316
2019-09-29
2019-12-28
0000743316
2018-07-01
2018-12-29
0000743316
2018-12-29
0000743316
2018-06-30
0000743316
us-gaap:RetainedEarningsMember
2019-09-29
2019-12-28
0000743316
us-gaap:AdditionalPaidInCapitalMember
2019-09-29
2019-12-28
0000743316
us-gaap:CommonStockMember
2019-09-29
2019-12-28
0000743316
2019-06-30
2019-09-28
0000743316
us-gaap:CommonStockMember
2019-12-28
0000743316
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-06-30
2019-09-28
0000743316
us-gaap:CommonStockMember
2019-06-30
2019-09-28
0000743316
us-gaap:RetainedEarningsMember
2019-12-28
0000743316
us-gaap:CommonStockMember
2019-09-28
0000743316
us-gaap:RetainedEarningsMember
2019-06-30
2019-09-28
0000743316
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-12-28
0000743316
us-gaap:CommonStockMember
2018-07-01
2018-12-29
0000743316
us-gaap:AdditionalPaidInCapitalMember
2018-07-01
2018-12-29
0000743316
us-gaap:CommonStockMember
2018-06-30
0000743316
us-gaap:CommonStockMember
2018-12-29
0000743316
us-gaap:RetainedEarningsMember
2017-06-25
2018-06-30
0000743316
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-06-25
2018-06-30
0000743316
2017-06-25
2018-06-30
0000743316
us-gaap:RetainedEarningsMember
2018-12-29
0000743316
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-29
0000743316
us-gaap:RetainedEarningsMember
2018-07-01
2018-12-29
0000743316
us-gaap:AdditionalPaidInCapitalMember
2019-06-30
2019-12-28
0000743316
us-gaap:RetainedEarningsMember
2019-06-30
2019-12-28
0000743316
us-gaap:CommonStockMember
2019-06-30
2019-12-28
0000743316
us-gaap:CommonStockMember
2019-06-29
0000743316
us-gaap:CommonStockMember
2018-07-01
2019-06-29
0000743316
us-gaap:RetainedEarningsMember
2018-07-01
2019-06-29
0000743316
2018-07-01
2019-06-29
0000743316
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-07-01
2019-06-29
0000743316
us-gaap:AdditionalPaidInCapitalMember
2018-09-30
2018-12-29
0000743316
us-gaap:RetainedEarningsMember
2018-09-30
2018-12-29
0000743316
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-09-30
2018-12-29
0000743316
us-gaap:CommonStockMember
2018-09-30
2018-12-29
0000743316
2017-06-25
2017-09-23
0000743316
us-gaap:RetainedEarningsMember
2017-06-25
2017-09-23
0000743316
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-06-25
2017-09-23
0000743316
2019-06-30
0000743316
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:AccruedLiabilitiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:AccruedLiabilitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-06-29
0000743316
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:AccruedLiabilitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
us-gaap:ForeignExchangeForwardMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-28
0000743316
mxim:ForwardcontractsheldtopurchaseU.S.dollarsMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-06-29
0000743316
mxim:FixedRateNoteDueMarch2023At3Point375PercentMember
2013-03-30
0000743316
mxim:ForwardcontractsheldtopurchaseU.S.dollarsMember
us-gaap:NondesignatedMember
2019-06-29
0000743316
mxim:FixedRateNoteDueJune2027at3Point450PercentMemberMember
2017-06-24
0000743316
mxim:ForwardcontractsheldtosellU.S.dollarsMember
us-gaap:NondesignatedMember
2019-12-28
0000743316
2016-06-26
2017-06-24
0000743316
mxim:FxedRateNoteDueMarch2023at3Point375PercentMember
2013-03-30
0000743316
mxim:FixedRateNoteDueJune2027at3Point50PercentMemberMember
2017-06-24
0000743316
mxim:FxedRateNoteDueMarch2023at3Point375PercentMember
2019-06-29
0000743316
mxim:ForwardcontractsheldtosellU.S.dollarsMember
us-gaap:NondesignatedMember
2019-06-29
0000743316
mxim:ForwardcontractsheldtopurchaseU.S.dollarsMember
us-gaap:NondesignatedMember
2019-12-28
0000743316
mxim:FixedRateNoteDueNovember2018at2Point50PercentMember
2019-06-29
0000743316
mxim:ForwardcontractsheldtopurchaseU.S.dollarsMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-12-28
0000743316
mxim:FixedRateNoteDueJune2027at3Point50PercentMemberDomain
2017-06-24
0000743316
mxim:FixedRateNoteDueJune2027at3Point45PercentMember
2017-06-24
0000743316
us-gaap:CorporateDebtSecuritiesMember
2019-06-29
0000743316
us-gaap:CertificatesOfDepositMember
2019-12-28
0000743316
us-gaap:CertificatesOfDepositMember
2019-06-29
0000743316
us-gaap:CorporateDebtSecuritiesMember
2019-12-28
0000743316
mxim:FixedRateNoteDueJune2027at3Point45PercentMember
2019-06-29
0000743316
mxim:FxedRateNoteDueMarch2023at3Point375PercentMember
2019-12-28
0000743316
mxim:FixedRateNoteDueJune2027at3Point45PercentMember
2019-12-28
0000743316
mxim:AccumulatedNetGainLossfromNetRevenueAttributabletoParentMember
2019-09-29
2019-12-28
0000743316
mxim:AccumulatedNetGainLossfromCostofGoodSoldsAttributabletoParentMemberMember
2019-09-29
2019-12-28
0000743316
mxim:AccumulatedNetGainLossfromNetRevenueAttributabletoParentMember
2018-09-30
2018-12-29
0000743316
mxim:AccumulatedNetGainLossfromOperatingExpenseAttributabletoParentMemberMemberMember
2019-09-29
2019-12-28
0000743316
mxim:AccumulatedNetGainLossfromCostofGoodSoldsAttributabletoParentMemberMember
2018-09-30
2018-12-29
0000743316
mxim:AccumulatedNetGainLossfromOperatingExpenseAttributabletoParentMemberMemberMember
2018-09-30
2018-12-29
0000743316
mxim:AccumulatedNetGainLossfromNetRevenueAttributabletoParentMember
2018-07-01
2018-12-29
0000743316
mxim:AccumulatedNetGainLossfromNetRevenueAttributabletoParentMember
2019-06-30
2019-12-28
0000743316
mxim:AccumulatedNetGainLossfromCostofGoodSoldsAttributabletoParentMemberMember
2019-06-30
2019-12-28
0000743316
mxim:AccumulatedNetGainLossfromOperatingExpenseAttributabletoParentMemberMemberMember
2018-07-01
2018-12-29
0000743316
mxim:AccumulatedNetGainLossfromOperatingExpenseAttributabletoParentMemberMemberMember
2019-06-30
2019-12-28
0000743316
mxim:AccumulatedNetGainLossfromCostofGoodSoldsAttributabletoParentMemberMember
2018-07-01
2018-12-29
0000743316
mxim:FixedRateNoteDueMarch2023At3Point375PercentMember
2019-12-28
0000743316
mxim:FixedRateNoteDueMarch2023At3Point375PercentMember
2019-06-29
0000743316
mxim:FixedRateNoteDueNovember2018at2Point50PercentMember
2019-12-28
0000743316
mxim:FixedRateNoteDueJune2027at3Point450PercentMemberMember
2019-12-28
0000743316
mxim:FixedRateNoteDueJune2027at3Point450PercentMemberMember
2019-06-29
0000743316
us-gaap:EmployeeStockOptionMember
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
2019-06-30
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
2019-06-29
0000743316
us-gaap:EmployeeStockMember
2018-09-30
2018-12-29
0000743316
us-gaap:EmployeeStockMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockMember
2019-06-30
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
2019-06-30
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
2019-06-29
0000743316
mxim:MarketStockUnitsMember
2019-12-28
0000743316
mxim:MarketStockUnitsMember
2019-06-30
2019-12-28
0000743316
mxim:MarketStockUnitsMember
2019-06-29
0000743316
us-gaap:GeneralAndAdministrativeExpenseMember
2018-09-30
2018-12-29
0000743316
us-gaap:EmployeeStockMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-09-29
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-09-30
2018-12-29
0000743316
us-gaap:EmployeeStockMember
us-gaap:CostOfSalesMember
2018-09-30
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
2019-09-29
2019-12-28
0000743316
us-gaap:ResearchAndDevelopmentExpenseMember
2019-09-29
2019-12-28
0000743316
us-gaap:ResearchAndDevelopmentExpenseMember
2018-09-30
2018-12-29
0000743316
us-gaap:EmployeeStockMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-09-30
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:GeneralAndAdministrativeExpenseMember
2018-09-30
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockMember
us-gaap:CostOfSalesMember
2019-09-29
2019-12-28
0000743316
us-gaap:CostOfSalesMember
2018-09-30
2018-12-29
0000743316
us-gaap:GeneralAndAdministrativeExpenseMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:CostOfSalesMember
2019-09-29
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:CostOfSalesMember
2019-09-29
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:CostOfSalesMember
2018-09-30
2018-12-29
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:GeneralAndAdministrativeExpenseMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-09-30
2018-12-29
0000743316
us-gaap:EmployeeStockMember
us-gaap:GeneralAndAdministrativeExpenseMember
2018-09-30
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:GeneralAndAdministrativeExpenseMember
2019-09-29
2019-12-28
0000743316
us-gaap:CostOfSalesMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:GeneralAndAdministrativeExpenseMember
2018-09-30
2018-12-29
0000743316
us-gaap:EmployeeStockMember
us-gaap:GeneralAndAdministrativeExpenseMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:CostOfSalesMember
2018-09-30
2018-12-29
0000743316
us-gaap:EmployeeStockOptionMember
2018-09-30
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
2018-09-30
2018-12-29
0000743316
us-gaap:PerformanceSharesMember
2019-06-30
2019-12-28
0000743316
us-gaap:PerformanceSharesMember
2018-07-01
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockMember
2018-12-29
0000743316
us-gaap:PerformanceSharesMember
2018-09-30
2018-12-29
0000743316
mxim:MarketStockUnitsMSUMemberDomain
2019-12-28
0000743316
us-gaap:EmployeeStockMember
2019-12-28
0000743316
mxim:MarketStockUnitsMember
2019-09-29
2019-12-28
0000743316
us-gaap:RestrictedStockMember
2019-12-28
0000743316
us-gaap:PerformanceSharesMember
2019-09-29
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
2018-07-01
2018-12-29
0000743316
us-gaap:ResearchAndDevelopmentExpenseMember
2019-06-30
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:GeneralAndAdministrativeExpenseMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:CostOfSalesMember
2019-06-30
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:GeneralAndAdministrativeExpenseMember
2019-06-30
2019-12-28
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-06-30
2019-12-28
0000743316
us-gaap:EmployeeStockMember
us-gaap:GeneralAndAdministrativeExpenseMember
2018-07-01
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:CostOfSalesMember
2019-06-30
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockMember
us-gaap:CostOfSalesMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockMember
us-gaap:GeneralAndAdministrativeExpenseMember
2019-06-30
2019-12-28
0000743316
us-gaap:EmployeeStockMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-06-30
2019-12-28
0000743316
us-gaap:GeneralAndAdministrativeExpenseMember
2018-07-01
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:GeneralAndAdministrativeExpenseMember
2019-06-30
2019-12-28
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-06-30
2019-12-28
0000743316
us-gaap:GeneralAndAdministrativeExpenseMember
2019-06-30
2019-12-28
0000743316
us-gaap:EmployeeStockMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-01
2018-12-29
0000743316
us-gaap:CostOfSalesMember
2018-07-01
2018-12-29
0000743316
us-gaap:RestrictedStockUnitsRSUMember
us-gaap:CostOfSalesMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:CostOfSalesMember
2018-07-01
2018-12-29
0000743316
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockOptionMember
us-gaap:GeneralAndAdministrativeExpenseMember
2018-07-01
2018-12-29
0000743316
us-gaap:EmployeeStockMember
us-gaap:CostOfSalesMember
2019-06-30
2019-12-28
0000743316
us-gaap:CostOfSalesMember
2019-06-30
2019-12-28
0000743316
country:CN
2019-06-30
2019-12-28
0000743316
country:CN
2019-09-29
2019-12-28
0000743316
mxim:RestOfAsiaMember
2019-06-30
2019-12-28
0000743316
country:US
2019-06-30
2019-12-28
0000743316
mxim:RestOfAsiaMember
2019-09-29
2019-12-28
0000743316
srt:EuropeMember
2019-09-29
2019-12-28
0000743316
srt:EuropeMember
2019-06-30
2019-12-28
0000743316
mxim:RestOfWorldMember
2018-09-30
2018-12-29
0000743316
country:CN
2018-07-01
2018-12-29
0000743316
mxim:RestOfAsiaMember
2018-07-01
2018-12-29
0000743316
country:US
2018-09-30
2018-12-29
0000743316
srt:EuropeMember
2018-07-01
2018-12-29
0000743316
country:US
2019-09-29
2019-12-28
0000743316
mxim:RestOfWorldMember
2018-07-01
2018-12-29
0000743316
country:US
2018-07-01
2018-12-29
0000743316
srt:EuropeMember
2018-09-30
2018-12-29
0000743316
country:CN
2018-09-30
2018-12-29
0000743316
mxim:RestOfWorldMember
2019-09-29
2019-12-28
0000743316
mxim:RestOfAsiaMember
2018-09-30
2018-12-29
0000743316
mxim:RestOfWorldMember
2019-06-30
2019-12-28
0000743316
country:US
2019-12-28
0000743316
country:US
2019-06-29
0000743316
mxim:RestOfWorldMember
2019-06-29
0000743316
country:PH
2019-06-29
0000743316
country:PH
2019-12-28
0000743316
mxim:RestOfWorldMember
2019-12-28
0000743316
mxim:UnrealizedHoldingGainslossesonAvailableforsaleInvestmentsMember
2018-12-29
0000743316
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-07-01
2018-12-29
0000743316
mxim:UnrealizedHoldingGainslossesonAvailableforsaleInvestmentsMember
2018-07-01
2018-12-29
0000743316
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-12-29
0000743316
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-12-29
0000743316
us-gaap:AccumulatedTranslationAdjustmentMember
2018-07-01
2018-12-29
0000743316
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-29
0000743316
mxim:UnrealizedHoldingGainsLossesonIntercompanyReceivablesMember
2018-07-01
2018-12-29
0000743316
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-07-01
2018-12-29
0000743316
mxim:UnrealizedHoldingGainslossesonAvailableforsaleInvestmentsMember
2018-06-30
0000743316
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-06-30
0000743316
mxim:UnrealizedHoldingGainsLossesonIntercompanyReceivablesMember
2018-12-29
0000743316
us-gaap:AccumulatedTranslationAdjustmentMember
2018-06-30
0000743316
mxim:UnrealizedHoldingGainsLossesonIntercompanyReceivablesMember
2018-06-30
0000743316
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-06-30
0000743316
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-06-30
2019-12-28
0000743316
mxim:UnrealizedHoldingGainslossesonAvailableforsaleInvestmentsMember
2019-06-30
2019-12-28
0000743316
mxim:UnrealizedHoldingGainsLossesonIntercompanyReceivablesMember
2019-12-28
0000743316
mxim:UnrealizedHoldingGainsLossesonIntercompanyReceivablesMember
2019-06-30
2019-12-28
0000743316
us-gaap:AccumulatedTranslationAdjustmentMember
2019-12-28
0000743316
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2019-12-28
0000743316
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2019-06-30
2019-12-28
0000743316
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-06-29
0000743316
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2019-06-29
0000743316
mxim:UnrealizedHoldingGainslossesonAvailableforsaleInvestmentsMember
2019-12-28
0000743316
us-gaap:AccumulatedTranslationAdjustmentMember
2019-06-30
2019-12-28
0000743316
mxim:UnrealizedHoldingGainsLossesonIntercompanyReceivablesMember
2019-06-29
0000743316
mxim:UnrealizedHoldingGainslossesonAvailableforsaleInvestmentsMember
2019-06-29
0000743316
us-gaap:AccumulatedTranslationAdjustmentMember
2019-06-29
0000743316
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-12-28
0000743316
2018-10-30
0000743316
us-gaap:IntellectualPropertyMember
2019-06-29
0000743316
us-gaap:TradeNamesMember
2019-12-28
0000743316
us-gaap:InProcessResearchAndDevelopmentMember
2019-06-29
0000743316
us-gaap:TradeNamesMember
2019-06-29
0000743316
us-gaap:IntellectualPropertyMember
2019-12-28
0000743316
us-gaap:PatentsMember
2019-06-29
0000743316
us-gaap:CustomerRelationshipsMember
2019-12-28
0000743316
us-gaap:InProcessResearchAndDevelopmentMember
2019-12-28
0000743316
us-gaap:CustomerRelationshipsMember
2019-06-29
0000743316
us-gaap:PatentsMember
2019-12-28
xbrli:shares
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:pure
mxim:customers
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
| | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the quarterly period ended | December 28, 2019 |
OR
|
| |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the transition period from ________ to ________. |
Commission file number 1-34192
MAXIM INTEGRATED PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
|
| | |
Delaware | | 94-2896096 |
(State or Other Jurisdiction of Incorporation or Organization) | | (I.R.S. Employer I. D. No.) |
160 Rio Robles
San Jose, California 95134
(Address of Principal Executive Offices including Zip Code)
(408) 601-1000
(Registrant’s Telephone Number, Including Area Code)
|
| | |
Title of each class | Trading Symbol | Name of each exchange on which registered |
Common stock, $0.001 par value | MXIM | The NASDAQ Global Select Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller” reporting company in Rule 12b-2 of the Exchange Act. (Check one): |
| | | | | | | | | |
Large accelerated filer | ☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | ☐ | Emerging growth company
| ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisited financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). (Check one): Yes ☐ No ☒
As of January 17, 2020, there were 269,394,184 shares of Common Stock, par value $.001 per share, of the registrant outstanding.
MAXIM INTEGRATED PRODUCTS, INC.
INDEX
|
| | |
PART I - FINANCIAL INFORMATION | | Page |
| | |
Item 1. Financial Statements (Unaudited) | | |
| | |
Condensed Consolidated Balance Sheets as of December 28, 2019 and June 29, 2019 | | |
| | |
Condensed Consolidated Statements of Income for the Three and Six Months Ended December 28, 2019 and December 29, 2018 | | |
| | |
Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended December 28, 2019 and December 29, 2018 | | |
| | |
Condensed Consolidated Statements of Shareholders' Equity for the Three and Six Months Ended December 28, 2019 and December 29, 2018 | | |
| | |
Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 28, 2019 and December 29, 2018 | | |
| | |
Notes to Condensed Consolidated Financial Statements | | |
| | |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | | |
| | |
Item 3. Quantitative and Qualitative Disclosures About Market Risk | | |
| | |
Item 4. Controls and Procedures | | |
| | |
PART II - OTHER INFORMATION | | |
| | |
Item 1. Legal Proceedings | | |
| | |
Item 1A. Risk Factors | | |
| | |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | | |
| | |
Item 3. Defaults Upon Senior Securities | | |
| | |
Item 4. Mine Safety Disclosures | | |
| | |
Item 5. Other Information | | |
| | |
Item 6. Exhibits | | |
| | |
SIGNATURE | | |
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
MAXIM INTEGRATED PRODUCTS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
| | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| (in thousands) |
ASSETS |
Current assets: | | | |
Cash and cash equivalents | $ | 1,720,194 |
| | $ | 1,757,342 |
|
Short-term investments | 63,006 |
| | 140,990 |
|
Total cash, cash equivalents and short-term investments | 1,783,200 |
| | 1,898,332 |
|
Accounts receivable, net of allowances of $723 at December 28, 2019 and $148 at June 29, 2019 | 348,342 |
| | 360,016 |
|
Inventories | 223,958 |
| | 246,512 |
|
Other current assets | 23,797 |
| | 34,640 |
|
Total current assets | 2,379,297 |
| | 2,539,500 |
|
Property, plant and equipment, net | 571,359 |
| | 577,722 |
|
Intangible assets, net | 48,509 |
| | 56,242 |
|
Goodwill | 532,251 |
| | 532,251 |
|
Other assets | 95,413 |
| | 38,267 |
|
TOTAL ASSETS | $ | 3,626,829 |
| | $ | 3,743,982 |
|
| | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY |
Current liabilities: | | | |
Accounts payable | $ | 89,449 |
| | $ | 84,335 |
|
Price adjustment and other revenue reserves | 105,237 |
| | 100,490 |
|
Income taxes payable | 38,307 |
| | 33,765 |
|
Accrued salary and related expenses | 94,739 |
| | 118,704 |
|
Accrued expenses | 32,739 |
| | 33,873 |
|
Total current liabilities | 360,471 |
| | 371,167 |
|
Long-term debt | 993,303 |
| | 992,584 |
|
Income taxes payable | 433,743 |
| | 469,418 |
|
Other liabilities | 112,803 |
| | 65,537 |
|
Total liabilities | 1,900,320 |
| | 1,898,706 |
|
| | | |
Commitments and contingencies (Note 11) |
|
| |
|
|
| | | |
Stockholders’ equity: | | | |
Common stock and capital in excess of par value | 270 |
| | 272 |
|
Retained earnings | 1,737,528 |
| | 1,856,358 |
|
Accumulated other comprehensive loss | (11,289 | ) | | (11,354 | ) |
Total stockholders’ equity | 1,726,509 |
| | 1,845,276 |
|
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY | $ | 3,626,829 |
| | $ | 3,743,982 |
|
See accompanying Notes to Condensed Consolidated Financial Statements.
MAXIM INTEGRATED PRODUCTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| December 28, 2019 | | December 29, 2018 | | December 28, 2019 | | December 29, 2018 |
| (in thousands, except per share data) |
| | | | | | | |
Net revenues | $ | 551,070 |
| | $ | 576,906 |
| | $ | 1,084,110 |
| | $ | 1,215,401 |
|
Cost of goods sold | 190,546 |
| | 203,858 |
| | 380,263 |
| | 412,117 |
|
Gross margin | 360,524 |
| | 373,048 |
| | 703,847 |
| | 803,284 |
|
Operating expenses: | | | | | | | |
Research and development | 111,914 |
| | 110,303 |
| | 220,903 |
| | 223,011 |
|
Selling, general and administrative | 76,071 |
| | 77,853 |
| | 152,186 |
| | 159,372 |
|
Intangible asset amortization | 756 |
| | 756 |
| | 1,512 |
| | 1,529 |
|
Impairment of long-lived assets | — |
| | 753 |
| | — |
| | 753 |
|
Severance and restructuring expenses | 2,728 |
| | 1,179 |
| | 4,162 |
| | 2,173 |
|
Other operating expenses (income), net | (1 | ) | | — |
| | 24 |
| | 60 |
|
Total operating expenses | 191,468 |
| | 190,844 |
| | 378,787 |
| | 386,898 |
|
Operating income | 169,056 |
| | 182,204 |
| | 325,060 |
| | 416,386 |
|
Interest and other income (expense), net | (17 | ) | | 472 |
| | 1,812 |
| | (74 | ) |
Income before provision for income taxes | 169,039 |
| | 182,676 |
| | 326,872 |
| | 416,312 |
|
Income tax provision | 22,989 |
| | 50,784 |
| | 40,666 |
| | 86,997 |
|
Net income | $ | 146,050 |
| | $ | 131,892 |
| | $ | 286,206 |
| | $ | 329,315 |
|
| | | | | | | |
Earnings per share: | | | | | | | |
Basic | $ | 0.54 |
| | $ | 0.48 |
| | $ | 1.06 |
| | $ | 1.19 |
|
Diluted | $ | 0.53 |
| | $ | 0.47 |
| | $ | 1.04 |
| | $ | 1.17 |
|
| | | | | | | |
Shares used in the calculation of earnings per share: | | | | | | | |
Basic | 270,330 |
| | 276,252 |
| | 270,859 |
| | 277,144 |
|
Diluted | 273,269 |
| | 280,008 |
| | 273,884 |
| | 281,414 |
|
See accompanying Notes to Condensed Consolidated Financial Statements.
MAXIM INTEGRATED PRODUCTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| December 28, 2019 | | December 29, 2018 | | December 28, 2019 | | December 29, 2018 |
| | | | | (in thousands) |
Net income | $ | 146,050 |
| | $ | 131,892 |
| | $ | 286,206 |
| | $ | 329,315 |
|
Other comprehensive income (loss), net of tax: | | | | | | | |
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $(3), $(201), $(17) and $(228), respectively | — |
| | 885 |
| | 118 |
| | 1,977 |
|
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $(117), $(96), $48 and $(310), respectively | 610 |
| | 423 |
| | (249 | ) | | 1,518 |
|
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(20), $(18), $(42) and $(37), respectively | 98 |
| | 76 |
| | 196 |
| | 154 |
|
Other comprehensive income (loss), net | 708 |
| | 1,384 |
| | 65 |
| | 3,649 |
|
Total comprehensive income | $ | 146,758 |
| | $ | 133,276 |
| | $ | 286,271 |
| | $ | 332,964 |
|
See accompanying Notes to Condensed Consolidated Financial Statements.
MAXIM INTEGRATED PRODUCTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
| | | | | | | |
| Six Months Ended |
| December 28, 2019 | | December 29, 2018 |
| (in thousands) |
Cash flows from operating activities: | | | |
Net income | $ | 286,206 |
| | $ | 329,315 |
|
Adjustments to reconcile net income to net cash provided by operating activities: | | | |
Stock-based compensation | 48,738 |
| | 42,153 |
|
Depreciation and amortization | 48,008 |
| | 57,994 |
|
Deferred taxes | (2,231 | ) | | (8,206 | ) |
Loss (gain) on disposal of property, plant and equipment | 489 |
| | 2,896 |
|
Other adjustments | 5,961 |
| | 636 |
|
Changes in assets and liabilities: | | | |
Accounts receivable | 16,421 |
| | 19,798 |
|
Inventories | 22,583 |
| | 3,497 |
|
Other assets | (55,820 | ) | | (6,587 | ) |
Accounts payable | 4,844 |
| | 2,401 |
|
Income taxes payable | (31,133 | ) | | 33,261 |
|
Accrued salary and related expenses | (23,965 | ) | | (45,783 | ) |
Other liabilities | 58,634 |
| | 60 |
|
Net cash provided by (used in) operating activities | 378,735 |
| | 431,435 |
|
Cash flows from investing activities: | | | |
Purchases of property, plant and equipment | (34,301 | ) | | (30,913 | ) |
Proceeds from sale of property, plant and equipment | 171 |
| | 2 |
|
Proceeds from sale of available-for-sale securities | — |
| | 27,253 |
|
Proceeds from maturity of available-for-sale securities | 78,067 |
| | 718,554 |
|
Payment in connection with business acquisition, net of cash acquired | — |
| | (2,949 | ) |
Purchases of available-for-sale securities | — |
| | (214,587 | ) |
Purchases of private company investments | — |
| | (906 | ) |
Other investing activities | (68 | ) | | — |
|
Net cash provided by (used in) investing activities | 43,869 |
| | 496,454 |
|
Cash flows from financing activities: | | | |
Repayment of debt | — |
| | (500,000 | ) |
Contingent consideration paid | (8,000 | ) | | (8,000 | ) |
Net issuance of restricted stock units | (17,566 | ) | | (13,444 | ) |
Proceeds from stock options exercised | 8,820 |
| | 13,843 |
|
Issuance of common stock under employee stock purchase program | 18,535 |
| | 17,689 |
|
Repurchase of common stock | (201,509 | ) | | (320,056 | ) |
Dividends paid | (260,032 | ) | | (254,665 | ) |
Net cash provided by (used in) financing activities | (459,752 | ) | | (1,064,633 | ) |
Net increase (decrease) in cash and cash equivalents | (37,148 | ) | | (136,744 | ) |
Cash and cash equivalents: | | | |
Beginning of period | $ | 1,757,342 |
| | $ | 1,543,484 |
|
End of period | $ | 1,720,194 |
| | $ | 1,406,740 |
|
Supplemental disclosures of cash flow information: | | | |
Cash paid, net, during the period for income taxes | $ | 63,692 |
| | $ | 60,946 |
|
Cash paid for interest | $ | 17,063 |
| | $ | 23,313 |
|
Noncash financing and investing activities: | | | |
Accounts payable related to property, plant and equipment purchases | $ | 12,360 |
| | $ | 14,660 |
|
See accompanying Notes to Condensed Consolidated Financial Statements.
MAXIM INTEGRATED PRODUCTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended December 28, 2019 |
| Common Stock | | Additional Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Total Stockholders' Equity |
| Shares | | Par Value | | | | |
| (in thousands) |
| | | | | | | | | | | |
Balance, September 28, 2019 | 270,883 |
| | $ | 271 |
| | $ | — |
| | $ | 1,793,012 |
| | $ | (11,997 | ) | | $ | 1,781,286 |
|
Net income | — |
| | — |
| | — |
| | 146,050 |
| | — |
| | 146,050 |
|
Other comprehensive income (loss), net | — |
| | — |
| | — |
| | — |
| | 708 |
| | 708 |
|
Repurchase of common stock | (1,862 | ) | | (1 | ) | | (36,321 | ) | | (71,635 | ) | | — |
| | (107,957 | ) |
Cumulative-effect adjustment for adoption of ASU 2016-02 | — |
| | — |
| | — |
| | (89 | ) | | — |
| | (89 | ) |
Net issuance of restricted stock units | 270 |
| | — |
| | (7,623 | ) | | — |
| | — |
| | (7,623 | ) |
Stock options exercised | 50 |
| | — |
| | 1,338 |
| | — |
| | — |
| | 1,338 |
|
Stock-based compensation | — |
| | — |
| | 24,071 |
| | — |
| | — |
| | 24,071 |
|
Common stock issued under Employee Stock Purchase Plan | 402 |
| | — |
| | 18,535 |
| | — |
| | — |
| | 18,535 |
|
Dividends paid, $0.48 per common share | — |
| | — |
| | — |
| | (129,810 | ) | | — |
| | (129,810 | ) |
Balance, December 28, 2019 | 269,743 |
| | $ | 270 |
| | $ | — |
| | $ | 1,737,528 |
| | $ | (11,289 | ) | | $ | 1,726,509 |
|
| | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | |
| Six Months Ended December 28, 2019 |
| Common Stock | | Additional Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Total Stockholders' Equity |
| Shares | | Par Value | | | | |
| (in thousands) |
| | | | | | | | | | | |
Balance, June 29, 2019 | 271,852 |
| | $ | 272 |
| | $ | — |
| | $ | 1,856,358 |
| | $ | (11,354 | ) | | $ | 1,845,276 |
|
Net income | — |
| | — |
| | — |
| | 286,206 |
| | — |
| | 286,206 |
|
Other comprehensive income (loss), net | — |
| | — |
| | — |
| | — |
| | 65 |
| | 65 |
|
Repurchase of common stock | (3,484 | ) | | (2 | ) | | (58,556 | ) | | (142,951 | ) | | — |
| | (201,509 | ) |
Cumulative-effect adjustment for adoption of ASU 2016-02 | — |
| | — |
| | — |
| | (2,053 | ) | | — |
| | (2,053 | ) |
Net issuance of restricted stock units | 657 |
| | — |
| | (17,566 | ) | | — |
| | — |
| | (17,566 | ) |
Stock options exercised | 316 |
| | — |
| | 8,820 |
| | — |
| | — |
| | 8,820 |
|
Stock-based compensation | — |
| | — |
| | 48,767 |
| | — |
| | — |
| | 48,767 |
|
Common stock issued under Employee Stock Purchase Plan | 402 |
| | — |
| | 18,535 |
| | — |
| | — |
| | 18,535 |
|
Dividends paid, $0.96 per common share | — |
| | — |
| | — |
| | (260,032 | ) | | — |
| | (260,032 | ) |
Balance, December 28, 2019 | 269,743 |
| | $ | 270 |
| | $ | — |
| | $ | 1,737,528 |
| | $ | (11,289 | ) | | $ | 1,726,509 |
|
| | | | | | | | | | | |
See accompanying Notes to Condensed Consolidated Financial Statements.
MAXIM INTEGRATED PRODUCTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended December 29, 2018 |
| Common Stock | | Additional Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Total Stockholders' Equity |
| Shares | | Par Value | | | | |
| (in thousands) |
| | | | | | | | | | | |
Balance, September 29, 2018 | 277,430 |
| | $ | 279 |
| | $ | — |
| | $ | 1,924,764 |
| | $ | (12,720 | ) | | $ | 1,912,323 |
|
Net income | — |
| | — |
| | — |
| | 131,892 |
| | — |
| | 131,892 |
|
Other comprehensive income (loss), net | — |
| | — |
| | — |
| | — |
| | 1,384 |
| | 1,384 |
|
Repurchase of common stock | (3,960 | ) | | — |
| | (44,181 | ) | | (163,377 | ) | | — |
| | (207,558 | ) |
Net issuance of restricted stock units | 281 |
| | — |
| | (5,916 | ) | | — |
| | — |
| | (5,916 | ) |
Stock options exercised | 191 |
| | — |
| | 7,235 |
| | — |
| | — |
| | 7,235 |
|
Stock-based compensation | — |
| | — |
| | 21,702 |
| | — |
| | — |
| | 21,702 |
|
Modification of liability to equity instruments (1) | — |
| | — |
| | 3,471 |
| | — |
| | — |
| | 3,471 |
|
Common stock issued under Employee Stock Purchase Plan | 384 |
| | — |
| | 17,689 |
| | — |
| | — |
| | 17,689 |
|
Dividends paid, $0.46 per common share | — |
| | — |
| | — |
| | (126,808 | ) | | — |
| | (126,808 | ) |
Balance, December 29, 2018 | 274,326 |
| | $ | 279 |
| | $ | — |
| | $ | 1,766,471 |
| | $ | (11,336 | ) | | $ | 1,755,414 |
|
| | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Six Months Ended December 29, 2018 |
| Common Stock | | Additional Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Total Stockholders' Equity |
| Shares | | Par Value | | | | |
| (in thousands) |
| | | | | | | | | | | |
Balance, June 30, 2018 | 278,664 |
| | $ | 279 |
| | $ | — |
| | $ | 1,945,646 |
| | $ | (14,985 | ) | | $ | 1,930,940 |
|
Net income | — |
| | — |
| | — |
| | 329,315 |
| | — |
| | 329,315 |
|
Other comprehensive income (loss), net | — |
| | — |
| | — |
| | — |
| | 3,649 |
| | 3,649 |
|
Repurchase of common stock | (5,822 | ) | | — |
| | (63,744 | ) | | (256,312 | ) | | — |
| | (320,056 | ) |
Cumulative-effect adjustment for adoption of ASU 2016-01 | — |
| — |
| — |
| | — |
| | 2,487 |
| | — |
| | 2,487 |
|
Net issuance of restricted stock units | 578 |
| | — |
| | (13,444 | ) | | — |
| | — |
| | (13,444 | ) |
Stock options exercised | 522 |
| | — |
| | 13,843 |
| | — |
| | — |
| | 13,843 |
|
Stock-based compensation | — |
| | — |
| | 42,185 |
| | — |
| | — |
| | 42,185 |
|
Modification of liability to equity instruments (1) | — |
| | — |
| | 3,471 |
| | — |
| | — |
| | 3,471 |
|
Common stock issued under Employee Stock Purchase Plan | 384 |
| | — |
| | 17,689 |
| | — |
| | — |
| | 17,689 |
|
Dividends paid, $0.92 per common share | — |
| | — |
| | — |
| | (254,665 | ) | | — |
| | (254,665 | ) |
Balance, December 29, 2018 | 274,326 |
|
|
| $ | 279 |
|
| $ | — |
|
| $ | 1,766,471 |
|
| $ | (11,336 | ) | | $ | 1,755,414 |
|
| | | | | | | | | | | |
________________
(1) In December 2018, $3.5 million was reclassified from accrued salaries to additional paid-in capital due to a settlement agreement relating to the expiration of stock options.
See accompanying Notes to Condensed Consolidated Financial Statements.
MAXIM INTEGRATED PRODUCTS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1: BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair statement have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the six months ended December 28, 2019 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 29, 2019.
The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal years 2019 and 2020 are 52-week fiscal years.
NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Recently Issued Accounting Pronouncements
(i) New Accounting Updates Recently Adopted
In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2016-02 (ASU 2016-02), Leases (Topic 842). Topic 842 states that lessees will recognize a lease liability for the commitment to make lease payments and a right-of-use asset for the underlying asset, for the duration of the lease. The FASB also issued ASU 2018-10 and ASU 2018-11 which provide improvements to ASU 2016-02 and an additional transition method option, respectively. This transition method allows a Company to apply the new lease accounting standard on adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings. The Company adopted ASU 2016-02 in the first quarter of fiscal year 2020.
The Company adopted the new standard using the modified retrospective method and electing the optional transition method practical expedient. Under the optional transition method, the Company recognized a cumulative-effect adjustment to the consolidated balance sheet and did not adjust comparative prior period information.
The Company elected multiple practical expedients permitted:
| |
• | the hindsight practical expedient, in which the Company elected to use hindsight up until the effective date in determining the lease term and assessing impairment of right-of-use assets; |
| |
• | the practical expedient package that allows the Company to carry forward its determination of whether a lease exists, the classification of a lease, and whether initial direct lease costs exist for purposes of transition to the new standard; and |
| |
• | the practical expedient to combine lease and non-lease components. |
The Company also elected an accounting policy in which it will not apply the recognition requirements to leases with an initial term of 12 months or less.
Effective June 30, 2019, the first day of adoption, the Company recognized $61.0 million of operating lease right-of-use assets and $65.2 million of operating lease liabilities on its Consolidated Balance Sheet. The difference of $4.2 million was primarily due to deferred rent, partially offset by prepaid rent for leases that existed as of the date of adoption, which decreased the opening balance of lease right-of-use (ROU) assets.
Updated Lease Accounting Policy
The Company determines if an arrangement is, or contains, a lease at inception. ROU assets are recorded as other assets, short-term lease obligations are recorded as accrued expenses and long-term lease obligations are recorded as other liabilities on the Company's Consolidated Balance Sheet. The Company’s classes of assets include real estate leases, equipment leases, and vehicle leases.
Lease ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. When discount rates implicit in leases cannot be readily determined, the Company uses its incremental borrowing rate based on information available at commencement date in determining the present value of future payments.
Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such option. Lease expense is recognized on a straight-line basis over the lease term. The Company elected to combine lease and non-lease components for all asset classes. In addition, the Company does not apply the recognition requirements to leases with lease terms of 12 months or less.
NOTE 3: BALANCE SHEET COMPONENTS
Inventories consist of:
|
| | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| (in thousands) |
Raw materials | $ | 13,222 |
| | $ | 16,121 |
|
Work-in-process | 142,551 |
| | 160,273 |
|
Finished goods | 68,185 |
| | 70,118 |
|
Total inventories | $ | 223,958 |
| | $ | 246,512 |
|
Property, plant and equipment, net, consist of:
|
| | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| (in thousands) |
Land | $ | 17,720 |
| | $ | 17,720 |
|
Buildings and building improvements | 306,052 |
| | 265,191 |
|
Machinery, equipment and software | 1,338,349 |
| | 1,367,606 |
|
Total | 1,662,121 |
| | 1,650,517 |
|
Less: accumulated depreciation | (1,090,762 | ) | | (1,072,795 | ) |
Total property, plant and equipment, net | $ | 571,359 |
| | $ | 577,722 |
|
Accrued salary and related expenses consist of:
|
| | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| (in thousands) |
Accrued vacation | $ | 31,223 |
| | $ | 30,251 |
|
Accrued bonus | 35,182 |
| | 71,466 |
|
Accrued salaries | 8,886 |
| | 8,329 |
|
Accrued fringe benefits | 6,397 |
| | 4,807 |
|
Other | 13,051 |
| | 3,851 |
|
Total accrued salary and related expenses | $ | 94,739 |
| | $ | 118,704 |
|
NOTE 4: FAIR VALUE MEASUREMENTS
The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows:
Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.
The Company’s Level 1 assets consist of money market funds.
Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
The Company’s Level 2 assets and liabilities consist of U.S. Treasury securities, agency securities, corporate debt securities, certificates of deposit, commercial paper and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates.
Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
The Company's Level 3 assets and liabilities consist of acquisition-related contingent consideration liabilities.
Assets and liabilities measured at fair value on a recurring basis were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| Fair Value Measurements Using | | Total Balance | | Fair Value Measurements Using | | Total Balance |
| Level 1 | | Level 2 | | Level 3 | | | Level 1 | | Level 2 | | Level 3 | |
| (in thousands) |
Assets | | | | | | | | | | | | | | | |
Cash and cash equivalents | | | | | | | | | | | | | | | |
Money market funds | $ | 175,298 |
| | $ | — |
| | $ | — |
| | $ | 175,298 |
| | $ | 186,819 |
| | $ | — |
| | $ | — |
| | $ | 186,819 |
|
Short-term investments | | | | | | |
|
| | | | | | | |
|
|
Certificates of deposit | — |
| | — |
| | — |
| | — |
| | — |
| | 1,000 |
| | — |
| | 1,000 |
|
Corporate debt securities | — |
| | 63,006 |
| | — |
| | 63,006 |
| | — |
| | 139,990 |
| | — |
| | 139,990 |
|
Other current assets | | | | | | | | | | | | | | | |
Foreign currency forward contracts | — |
| | 361 |
| | — |
| | 361 |
| | — |
| | 651 |
| | — |
| | 651 |
|
Total assets | $ | 175,298 |
| | $ | 63,367 |
| | $ | — |
| | $ | 238,665 |
| | $ | 186,819 |
| | $ | 141,641 |
| | $ | — |
| | $ | 328,460 |
|
| | | | | | | | | | | | | | | |
Liabilities | | | | | | | | | | | | | | | |
Accrued expenses | | | | | | | | | | | | | | | |
Foreign currency forward contracts | $ | — |
| | $ | 186 |
| | $ | — |
| | $ | 186 |
| | $ | — |
| | $ | 148 |
| | $ | — |
| | $ | 148 |
|
Contingent consideration | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 9,052 |
| | 9,052 |
|
Total Liabilities | $ | — |
| | $ | 186 |
| | $ | — |
| | $ | 186 |
| | $ | — |
| | $ | 148 |
| | $ | 9,052 |
| | $ | 9,200 |
|
During the six months ended December 28, 2019 and the year ended June 29, 2019, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.
There were no assets or liabilities measured at fair value on a non-recurring basis as of December 28, 2019 and June 29, 2019 other than impairments of long-lived assets.
As of December 28, 2019 and June 29, 2019, the fair value of private company investments amounted to $20.9 million and $20.7 million, respectively. The aggregate amount of unrealized losses recognized from these investments were $3.0 million and $3.6 million, respectively, as of December 28, 2019 and June 29, 2019.
The Company recorded $0.6 million and $(0.8) million of unrealized gains (losses) on private company investments, during the three months ended December 28, 2019 and December 29, 2018, respectively. The Company recorded $0.6 million and $(0.7) million, of unrealized gains (losses) on private company investments during the six months ended December 28, 2019 and December 29, 2018, respectively. Unrealized gains (losses) on private company investments are recorded in Interest and other income (expense), net in the Company's Condensed Consolidated Statements of Income.
NOTE 5: FINANCIAL INSTRUMENTS
Short-term investments
Fair values were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| Amortized Cost | | Gross Unrealized Gain | | Gross Unrealized Loss | | Estimated Fair Value | | Amortized Cost | | Gross Unrealized Gain | | Gross Unrealized Loss | | Estimated Fair Value |
| (in thousands) |
Available-for-sale investments | | | | | | | | | | | | | | |
Certificates of deposit | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1,000 |
| | $ | — |
| | $ | — |
| | $ | 1,000 |
|
Corporate debt securities | 62,929 |
| | 86 |
| | (9 | ) | | 63,006 |
| | 140,031 |
| | 68 |
| | (109 | ) | | 139,990 |
|
Total available-for-sale investments | $ | 62,929 |
| | $ | 86 |
| | $ | (9 | ) | | $ | 63,006 |
| | $ | 141,031 |
| | $ | 68 |
| | $ | (109 | ) | | $ | 140,990 |
|
In the three and six months ended December 28, 2019 and December 29, 2018, the Company did not recognize any impairment charges on short-term investments. All available-for-sale investments have maturity dates between January 15, 2020 and March 12, 2021.
The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes.
Derivative instruments and hedging activities
The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, for sales offices and research and development activities undertaken outside of the U.S.
The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.
Derivatives designated as cash flow hedging instruments
The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). As of December 28, 2019 and June 29, 2019, the notional amounts of the forward contracts the Company held to purchase international currencies were $41.4 million and $48.5 million, respectively. As of December 28, 2019 and June 29, 2019, the Company did not hold any forward contracts to sell international currencies.
Derivatives not designated as hedging instruments
As of December 28, 2019 and June 29, 2019, the notional amounts of the forward contracts the Company held to purchase international currencies were $50.3 million and $19.6 million, respectively, and the notional amounts of forward contracts the
Company held to sell international currencies were $20.7 million and $21.1 million, respectively. The increase in forward contracts held to purchase international currencies from fiscal year 2019 to fiscal year 2020 was primarily due to the addition of operating lease liabilities, which were recorded on the Company’s Consolidated Balance Sheet upon adoption of the new lease accounting standard, Topic 842. The Company's foreign currency forward contract gains or losses included in the Condensed Consolidated Statements of Income were not material for the three and six months ended December 28, 2019 and December 29, 2018, respectively.
Effect of hedge accounting on the Condensed Consolidated Statements of Income
The following tables summarize the gains (losses) from hedging activities recognized in the Company's Condensed Consolidated Statements of Income:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | Three Months Ended |
| December 28, 2019 | December 29, 2018 |
| Net Revenue | | Cost of Goods Sold | | Operating Expenses | | Net Revenue | | Cost of Goods Sold | | Operating Expenses |
| (in thousands) |
Income and expenses line items in which the effects of cash flow hedges are recorded | $ | 551,070 |
| | $ | 190,546 |
| | $ | 191,468 |
| | $ | 576,906 |
| | $ | 203,858 |
| | $ | 190,844 |
|
| | | | | | | | | | | |
Gain (loss) on cash flow hedges: | | | | | | | | | | | |
Foreign exchange contracts: | | | | | | | | | | | |
Gain (loss) reclassified from accumulated other comprehensive income into income | $ | — |
| | $ | 10 |
| | $ | (404 | ) | | $ | 5 |
| | $ | (82 | ) | | $ | (602 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Six Months Ended | Six Months Ended |
| December 28, 2019 | December 29, 2018 |
| Net Revenue | | Cost of Goods Sold | | Operating Expenses | | Net Revenue | | Cost of Goods Sold | | Operating Expenses |
| (in thousands) |
Income and expenses line items in which the effects of cash flow hedges are recorded | $ | 1,084,110 |
| | $ | 380,263 |
| | $ | 378,787 |
| | $ | 1,215,401 |
| | $ | 412,117 |
| | $ | 386,898 |
|
| | | | | | | | | | | |
Gain (loss) on cash flow hedges: | | | | | | | | | | | |
Foreign exchange contracts: | | | | | | | | | | | |
Gain (loss) reclassified from accumulated other comprehensive income into income | $ | — |
| | $ | 130 |
| | $ | (774 | ) | | $ | 44 |
| | $ | (596 | ) | | $ | (1,827 | ) |
Outstanding debt obligations
The following table summarizes the Company’s outstanding debt obligations:
|
| | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| (in thousands) |
3.45% fixed rate notes due June 2027 | $ | 500,000 |
| | $ | 500,000 |
|
3.375% fixed rate notes due March 2023 | 500,000 |
| | 500,000 |
|
Total outstanding debt | 1,000,000 |
| | 1,000,000 |
|
Less: Reduction for unamortized discount and debt issuance costs | (6,697 | ) | | (7,416 | ) |
Total long-term debt | $ | 993,303 |
| | $ | 992,584 |
|
On June 15, 2017, the Company completed a public offering of $500 million aggregate principal amount of the Company's 3.45% senior unsecured and unsubordinated notes due in June 2027 (“2027 Notes”), with an effective interest rate of 3.5%. Interest on the 2027 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2017. The net proceeds of this offering were approximately $495.2 million, after issuing at a discount and deducting paid expenses.
On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million, after issuing at a discount and deducting paid expenses. In November of 2018, the Company repaid the entire $500 million in principal and any outstanding interest, related to these outstanding notes.
On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5%. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million, after issuing at a discount and deducting paid expenses.
The debt indentures that govern the 2027 Notes and the 2023 Notes include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2027 Notes or the 2023 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest.
The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes, were $8.9 million and $11.2 million during the three months ended December 28, 2019 and December 29, 2018, respectively. Amortized discount and expenses, as well as interest expense associated with the notes, were $17.8 million and $23.6 million, respectively, during the six months ended December 28, 2019 and December 29, 2018.
The estimated fair value of the Company’s outstanding debt obligations was approximately $1.03 billion as of December 28, 2019. The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.
The Company recorded interest expense of $9.3 million and $11.7 million during the three months ended December 28, 2019, and December 29, 2018, respectively. The Company recorded interest expense of $18.6 million and $24.6 million during the six months ended December 28, 2019, and December 29, 2018, respectively.
Other Financial Instruments
For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.
NOTE 6: STOCK-BASED COMPENSATION
At December 28, 2019, the Company had one stock incentive plan, the Company's 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESPP”). The 1996 Plan was adopted by the Board of Directors to provide the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), and market stock units (“MSUs”) to employees, directors, and consultants.
Pursuant to the 1996 Plan, the exercise price for incentive stock options and non-statutory stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Options generally expire no later than seven years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service.
RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. RSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.
MSUs granted to employees typically vest over a four-year cliff period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are released at the end of the performance period can range from zero to a maximum cap depending on the Company's performance. MSUs granted after August 2017 will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.
The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and six months ended December 28, 2019 and December 29, 2018, respectively:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | | Three Months Ended |
| December 28, 2019 | | December 29, 2018 |
| Stock Options | | Restricted Stock Units | | Employee Stock Purchase Plan | | Total | | Stock Options | | Restricted Stock Units | | Employee Stock Purchase Plan | | Total |
| (in thousands) |
Cost of goods sold | $ | 5 |
| | $ | 2,269 |
| | $ | 699 |
| | $ | 2,973 |
| | $ | 9 |
| | $ | 1,884 |
| | $ | 495 |
| | $ | 2,388 |
|
Research and development | 4 |
| | 9,918 |
| | 1,514 |
| | 11,436 |
| | 11 |
| | 8,693 |
| | 1,135 |
| | 9,839 |
|
Selling, general and administrative | 55 |
| | 8,753 |
| | 849 |
| | 9,657 |
| | 58 |
| | 8,773 |
| | 598 |
| | 9,429 |
|
Pre-tax stock-based compensation expense | $ | 64 |
| | $ | 20,940 |
| | $ | 3,062 |
| | $ | 24,066 |
| | $ | 78 |
| | $ | 19,350 |
| | $ | 2,228 |
| | $ | 21,656 |
|
Less: income tax effect | | | | | | | 2,193 |
| | | | | | | | 2,304 |
|
Net stock-based compensation expense | | | | | | $ | 21,873 |
| | | | | | | | $ | 19,352 |
|
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Six Months Ended | | Six Months Ended |
| December 28, 2019 |
| December 29, 2018 |
| Stock Options |
| Restricted Stock Units |
| Employee Stock Purchase Plan |
| Total |
| Stock Options |
| Restricted Stock Units |
| Employee Stock Purchase Plan |
| Total |
| (in thousands) |
Cost of goods sold | $ | 14 |
|
| $ | 4,549 |
|
| $ | 1,368 |
|
| $ | 5,931 |
|
| $ | 19 |
|
| $ | 3,646 |
|
| $ | 1,002 |
|
| $ | 4,667 |
|
Research and development | 8 |
|
| 19,403 |
|
| 2,909 |
|
| 22,320 |
|
| 22 |
|
| 17,384 |
|
| 2,290 |
|
| 19,696 |
|
Selling, general and administrative | 122 |
|
| 18,706 |
|
| 1,659 |
|
| 20,487 |
|
| 114 |
|
| 16,417 |
|
| 1,259 |
|
| 17,790 |
|
Pre-tax stock-based compensation expense | $ | 144 |
|
| $ | 42,658 |
|
| $ | 5,936 |
|
| $ | 48,738 |
|
| $ | 155 |
|
| $ | 37,447 |
|
| $ | 4,551 |
|
| $ | 42,153 |
|
Less: income tax effect |
|
|
|
|
|
| 5,081 |
|
|
|
|
|
|
|
| 4,268 |
|
Net stock-based compensation expense |
|
|
|
|
|
| $ | 43,657 |
|
|
|
|
|
|
|
| $ | 37,885 |
|
The expense included in the Condensed Consolidated Statements of Income for RSUs include expenses related to MSUs of $2.4 million and $2.9 million for the three months ended December 28, 2019 and December 29, 2018, respectively, and $6.8 million and $5.3 million for the six months ended December 28, 2019 and December 29, 2018, respectively.
Stock Options
The fair value of options granted to employees under the 1996 Plan is estimated on the date of grant using the Black-Scholes option valuation model.
There were no stock options granted in the three and six months ended December 28, 2019 and December 29, 2018.
The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of December 28, 2019 and related activity for the six months ended December 28, 2019:
|
| | | | | | | | | | | | |
| Number of Shares | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (in Years) | | Aggregate Intrinsic Value(1) |
Balance at June 29, 2019 | 777,413 |
| | $ | 28.30 |
| | | | |
Options Granted | — |
| | — |
| | | | |
Options Exercised | (302,708 | ) | | 27.82 |
| | | | |
Options Cancelled | (16,575 | ) | | 27.30 |
| | | | |
Balance at December 28, 2019 | 458,130 |
| | $ | 28.49 |
| | 1.0 | | $ | 15,139,460 |
|
Exercisable, December 28, 2019 | 458,130 |
| | $ | 28.49 |
| | 1.0 | | $ | 15,139,460 |
|
Vested and expected to vest, December 28, 2019 | 458,130 |
| | $ | 28.49 |
| | 1.0 | | $ | 15,139,460 |
|
|
| |
(1) | Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of December 28, 2019. |
As of December 28, 2019, there was no unrecognized stock compensation from unvested stock options.
Restricted Stock Units and Other Awards
The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.
The weighted-average fair value of RSUs and other awards granted was $56.21 and $50.90 per share for the three months ended December 28, 2019 and December 29, 2018, respectively, and $48.30 and $54.71 per share for the six months ended December 28, 2019 and December 29, 2018, respectively.
The following table summarizes the outstanding and expected to vest RSUs and other awards as of December 28, 2019 and related activity during the six months ended December 28, 2019:
|
| | | | | | | | |
| Number of Shares | | Weighted Average Remaining Contractual Term (in Years) | | Aggregate Intrinsic Value(1) |
Balance at June 29, 2019 | 4,918,306 |
| | | | |
Restricted stock units and other awards granted | 1,550,765 |
| | | | |
Restricted stock units and other awards released | (795,156 | ) | | | | |
Restricted stock units and other awards cancelled | (269,743 | ) | | | | |
Balance at December 28, 2019 | 5,404,172 |
| | 2.8 | | $ | 332,572,745 |
|
Outstanding and expected to vest, December 28, 2019 | 4,513,314 |
| | 2.8 | | $ | 277,749,319 |
|
|
| |
(1) | Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of December 28, 2019. |
The Company withheld shares totaling $7.6 million and $17.6 million in value as a result of employee withholding taxes based on the value of RSUs on their vesting date for the three and six months ended December 28, 2019. Total payments for employees’ tax obligations to taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows.
As of December 28, 2019, there was $175.2 million of unrecognized compensation expense related to 5.4 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.8 years.
Market Stock Units (MSUs)
The Company grants MSUs to senior members of management in lieu of granting stock options. For MSUs granted prior to September 2017, the performance metrics of this program are based on relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index SPDR S&P (the “XSD”). For MSUs granted in September 2017 and after, the performance metrics for this program are based on the total shareholder return ("TSR") of the Company relative to the TSR of the other companies included in the XSD. The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD or the TSR of the companies included in the XSD, as applicable. Vesting for MSUs is contingent upon both service and market conditions and has a four-year vesting cliff period. MSUs granted after August 2017 vest based upon annual performance and are subject to continued service through the end of the four-year period but will continue to vest post-employment at the Company for certain individuals satisfying specific eligibility requirements.
The weighted-average fair value of MSUs granted was $54.70 and $75.48 per share for the six months ended December 28, 2019 and December 29, 2018, respectively.
The following table summarizes the number of MSUs outstanding and expected to vest as of December 28, 2019 and their activity during the six months ended December 28, 2019:
|
| | | | | | | | |
| Number of Shares | | Weighted Average Remaining Contractual Term (in Years) | | Aggregate Intrinsic Value(1) |
Balance at June 29, 2019 | 1,048,532 |
| | | | |
Market stock units granted | 259,984 |
| | | | |
Market stock units released | (183,974 | ) | | | | |
Market stock units cancelled | (140,290 | ) | | | | |
Balance at December 28, 2019 | 984,252 |
| | 2.8 | | $ | 60,570,868 |
|
Outstanding and expected to vest, December 28, 2019 | 350,417 |
| | 2.7 | | $ | 21,564,655 |
|
|
| |
(1) | Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on December 27, 2019, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of December 28, 2019. |
As of December 28, 2019, there was $32.4 million of unrecognized compensation expense related to 1.0 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 2.8 years.
Employee Stock Purchase Plan
Employees are granted rights to acquire common stock under the 2008 ESPP.
The fair value of 2008 ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding:
|
| | | | | | | |
| Three Months Ended | | Six Months Ended |
| December 28, 2019 | | December 29, 2018 | | December 28, 2019 | | December 29, 2018 |
Expected holding period (in years) | 0.5 years | | 0.5 years | | 0.5 years | | 0.5 years |
Risk-free interest rate | 1.6% - 2.7% | | 1.6% - 2.6% | | 1.6% - 2.7% | | 1.6% - 2.6% |
Expected stock price volatility | 28.4% - 31.3% | | 19.6% - 32.7% | | 28.4% - 31.3% | | 19.6% - 32.7% |
Dividend yield | 3.1% - 3.4% | | 2.1% - 3.1% | | 3.1% - 3.4% | | 2.1% - 3.1% |
As of December 28, 2019 and December 29, 2018, there was $10.1 million and $8.6 million, respectively, of unrecognized compensation expense related to the 2008 ESPP.
NOTE 7: EARNINGS PER SHARE
Basic earnings per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs and other awards as well as MSUs. Diluted earnings per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and other awards as well as MSUs, and assumed issuance of common stock under the 2008 ESPP using the treasury stock method.
The following table sets forth the computation of basic and diluted earnings per share:
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| December 28, 2019 | | December 29, 2018 | | December 28, 2019 | | December 29, 2018 |
| (in thousands, except per share data) |
Numerator for basic earnings per share and diluted earnings per share | | | | | | | |
Net income | $ | 146,050 |
| | $ | 131,892 |
| | $ | 286,206 |
| | $ | 329,315 |
|
| | | | | | | |
Denominator for basic earnings per share | 270,330 |
| | 276,252 |
| | 270,859 |
| | 277,144 |
|
Effect of dilutive securities: | | | | | | | |
Stock options, ESPP, RSUs, and MSUs | 2,939 |
| | 3,756 |
| | 3,025 |
| | 4,270 |
|
Denominator for diluted earnings per share | 273,269 |
| | 280,008 |
| | 273,884 |
| | 281,414 |
|
| | | | | | | |
Earnings per share | | | | | | | |
Basic | $ | 0.54 |
| | $ | 0.48 |
| | $ | 1.06 |
| | $ | 1.19 |
|
Diluted | $ | 0.53 |
| | $ | 0.47 |
| | $ | 1.04 |
| | $ | 1.17 |
|
For the three and six months ended December 28, 2019 and December 29, 2018 no stock awards were determined to be anti-dilutive. Securities which would have been anti-dilutive are insignificant and were excluded from the computation of diluted earnings per share in all periods.
NOTE 8: SEGMENT INFORMATION
The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. All of the Company's products are designed through a centralized R&D function, manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors.
The Company currently has one operating segment and reportable segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280”), the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment.
Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year.
Net revenues from unaffiliated customers by geographic region were as follows:
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| December 28, 2019 | | December 29, 2018 | | December 28, 2019 | | December 29, 2018 |
| (in thousands) |
United States | $ | 58,909 |
| | $ | 64,845 |
| | $ | 114,707 |
| | $ | 136,974 |
|
China | 217,099 |
| | 208,717 |
| | 414,398 |
| | 428,015 |
|
Rest of Asia | 163,563 |
| | 186,840 |
| | 333,478 |
| | 407,221 |
|
Europe | 98,254 |
| | 100,662 |
| | 194,194 |
| | 212,030 |
|
Rest of World | 13,245 |
| | 15,842 |
| | 27,333 |
| | 31,161 |
|
| $ | 551,070 |
| | $ | 576,906 |
| | $ | 1,084,110 |
| | $ | 1,215,401 |
|
Net long-lived assets by geographic region were as follows:
|
| | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| (in thousands) |
United States | $ | 375,860 |
| | $ | 379,308 |
|
Philippines | 97,784 |
| | 102,634 |
|
Rest of World | 97,715 |
| | 95,780 |
|
| $ | 571,359 |
| | $ | 577,722 |
|
NOTE 9: COMPREHENSIVE INCOME (LOSS)
The changes in accumulated other comprehensive income (loss) by component and related tax effects in the six months ended December 28, 2019 and December 29, 2018 were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | |
(in thousands) | Unrealized Gains and (Losses) on Intercompany Receivables | | Unrealized Gains and (Losses) on Post-Retirement Benefits | | Cumulative Translation Adjustment | | Unrealized Gains and (Losses) on Cash Flow Hedges | | Unrealized Gains and (Losses) on Available-For-Sale Securities | | Total |
June 29, 2019 | $ | (6,280 | ) | | $ | (4,322 | ) | | $ | (1,136 | ) | | $ | 425 |
| | $ | (41 | ) | | $ | (11,354 | ) |
Other comprehensive income (loss) before reclassifications | — |
| | — |
| | — |
| | (941 | ) | | 135 |
| | (806 | ) |
Amounts reclassified out of accumulated other comprehensive (income) loss | — |
| | 238 |
| | — |
| | 644 |
| | — |
| | 882 |
|
Tax effects | — |
| | (42 | ) | | — |
| | 48 |
| | (17 | ) | | (11 | ) |
Other comprehensive income (loss), net | — |
| | 196 |
| | — |
| | (249 | ) | | 118 |
| | 65 |
|
December 28, 2019 | $ | (6,280 | ) | | $ | (4,126 | ) | | $ | (1,136 | ) | | $ | 176 |
| | $ | 77 |
| | $ | (11,289 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | |
(in thousands) | Unrealized Gains and (Losses) on Intercompany Receivables | | Unrealized Gains and (Losses) on Post-Retirement Benefits | | Cumulative Translation Adjustment | | Unrealized Gains and (Losses) on Cash Flow Hedges | | Unrealized Gains and (Losses) on Available-For-Sale Securities | | Total |
June 30, 2018 | $ | (6,280 | ) | | $ | (2,516 | ) | | $ | (1,136 | ) | | $ | (1,383 | ) | | $ | (3,670 | ) | | $ | (14,985 | ) |
Other comprehensive income (loss) before reclassifications | — |
| | — |
| | — |
| | (551 | ) | | 2,205 |
| | 1,654 |
|
Amounts reclassified out of accumulated other comprehensive (income) loss | — |
| | 191 |
| | — |
| | 2,379 |
| | — |
| | 2,570 |
|
Tax effects | — |
| | (37 | ) | | — |
| | (310 | ) | | (228 | ) | | (575 | ) |
Other comprehensive income (loss), net | — |
| | 154 |
| | — |
| | 1,518 |
| | 1,977 |
| | 3,649 |
|
December 29, 2018 | $ | (6,280 | ) | | $ | (2,362 | ) | | $ | (1,136 | ) | | $ | 135 |
| | $ | (1,693 | ) | | $ | (11,336 | ) |
NOTE 10: INCOME TAXES
In the three and six months ended December 28, 2019 the Company recorded an income tax provision of $23.0 million and $40.7 million, respectively, compared to $50.8 million and $87.0 million for the three and six months ended December 29, 2018, respectively. The Company’s effective tax rate for the three and six months ended December 28, 2019 was 13.6% and 12.4%, respectively, compared to 27.8% and 20.9% for the three and six months ended December 29, 2018, respectively.
On December 22, 2017 legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of the Company's foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period, the Company gathered additional information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019, the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the three and six months ended December 29, 2018 by 12.1% and 5.3%, respectively. As of the end of the second quarter of fiscal year 2019, the accounting for income tax effects of the Act was completed.
The Company’s federal statutory tax rate is 21%. The Company’s effective tax rate for the three and six months ended December 28, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by U.S. tax expense related to Global Intangible Low-Taxed Income (“GILTI”).
The Company’s effective tax rate for the three months ended December 29, 2018 was higher than the statutory rate primarily due to a $22.1 million discrete charge for the Transition Tax, U.S. tax expense related to GILTI, and a $4.9 million discrete charge for interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates.
The Company’s effective tax rate for the six months ended December 29, 2018 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by a $22.1 million discrete charge for the Transition Tax, U.S. tax expense related to GILTI, and a $9.4 million discrete charge for interest accruals for unrecognized tax benefits.
The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that the balance of gross unrecognized tax benefits, including accrued interest and penalties, could decrease up to $56.0 million within the next twelve months due to the completion of federal tax audits, including any administrative appeals. The $56.0 million primarily relates to matters involving federal taxation of cross-border transactions.
The Company’s federal corporate income tax returns are audited on a recurring basis by the Internal Revenue Service (“IRS”). In fiscal year 2017, the IRS commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2012 through 2014, which is ongoing. In fiscal year 2020 the IRS commenced an audit of the Company's federal corporate income tax returns for fiscal years 2015 through 2017, which is ongoing.
NOTE 11: COMMITMENTS AND CONTINGENCIES
Legal Proceedings
The Company is party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual property matters. While the outcome of these matters cannot be predicted with certainty, the Company does not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any.
Indemnification
The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims.
Pursuant to the Company's charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.
NOTE 12: COMMON STOCK REPURCHASES
On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $1.5 billion of the Company’s common stock. The stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generated from operations, cash requirements, and other factors. All prior repurchase authorizations by the Company’s Board of Directors for the repurchase of common stock were cancelled and superseded by this repurchase authorization.
During the six months ended December 28, 2019, the Company repurchased approximately 3.5 million shares of its common stock for $201.5 million. As of December 28, 2019, the Company had remaining authorization of $0.9 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.
NOTE 13: LEASES
The Company's lease obligations consist of operating leases for domestic and international office facilities, data centers, and equipment. These leases expire at various dates through fiscal year 2031. For the three and six months ended December 28, 2019, the Company recorded operating lease expense of $2.9 million and $5.9 million, respectively.
Leases are included in the following Condensed Consolidated Balance Sheet lines:
|
| | | | |
| | December 28, 2019 |
| | (in thousands) |
Other assets | | $ | 56,170 |
|
| | |
Accrued expenses | | $ | 10,028 |
|
Other liabilities | | $ | 50,784 |
|
Future minimum lease payments under non-cancelable operating leases as of December 28, 2019 are as follows:
|
| | | | |
| | Operating Lease Obligations
|
Fiscal Year
| | (in thousands)
|
Remainder of 2020 | | $ | 5,969 |
|
2021 | | 11,818 |
|
2022 | | 10,847 |
|
2023 | | 9,599 |
|
2024 | | 8,202 |
|
Thereafter | | 21,904 |
|
Total | | 68,339 |
|
Less imputed interest | | 7,657 |
|
Total | | $ | 60,682 |
|
Other information related to leases as of December 28, 2019 are as follows:
|
| | | | |
| | Six Months Ended |
| | December 28, 2019 |
Supplemental cash flow information | | (in thousands) |
Operating cash flows used for operating leases | | $ | 5,911 |
|
Weighted-average remaining lease term - operating leases, in years | | 7 |
|
Weighted-average discount rate - operating leases | | 3.45 | % |
Since most of our operating leases do not provide an implicit interest rate, the Company used a portfolio approach to determine a collateralized incremental borrowing rate based on the information available at the commencement date to determine the lease liability.
NOTE 14: GOODWILL AND INTANGIBLE ASSETS
Goodwill
The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable.
There were no changes to goodwill during the six months ended December 28, 2019.
No indicators or instances of impairment were identified during the six months and fiscal year ended December 28, 2019 and June 29, 2019, respectively.
Intangible Assets
Intangible assets consisted of the following: |
| | | | | | | | | | | | | | | | | | | | | | | |
| December 28, 2019 | | June 29, 2019 |
| Original Cost | | Accumulated Amortization | | Net | | Original Cost | | Accumulated Amortization | | Net |
| (in thousands) |
Intellectual property | $ | 490,136 |
| | $ | 451,780 |
| | $ | 38,356 |
| | $ | 487,346 |
| | $ | 445,558 |
| | $ | 41,788 |
|
Customer relationships | 116,505 |
| | 107,244 |
| | 9,261 |
| | 116,505 |
| | 105,901 |
| | 10,604 |
|
Trade name | 9,974 |
| | 9,082 |
| | 892 |
| | 9,974 |
| | 8,914 |
| | 1,060 |
|
Patents | 2,500 |
| | 2,500 |
| | — |
| | 2,500 |
| | 2,500 |
| | — |
|
Total amortizable purchased intangible assets | 619,115 |
| | 570,606 |
| | 48,509 |
| | 616,325 |
| | 562,873 |
| | 53,452 |
|
In-process research & development (IPR&D) | — |
| | — |
| | — |
| | 2,790 |
| | — |
| | 2,790 |
|
Total purchased intangible assets | $ | 619,115 |
| | $ | 570,606 |
| | $ | 48,509 |
| | $ | 619,115 |
| | $ | 562,873 |
| | $ | 56,242 |
|
The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| December 28, 2019 | | December 29, 2018 | | December 28, 2019 | | December 29, 2018 |
| (in thousands) |
Cost of goods sold | $ | 3,111 |
| | $ | 6,868 |
| | $ | 6,221 |
| | $ | 13,783 |
|
Intangible asset amortization | 756 |
| | 756 |
| | 1,512 |
| | 1,529 |
|
Total intangible asset amortization expenses | $ | 3,867 |
| | $ | 7,624 |
| | $ | 7,733 |
| | $ | 15,312 |
|
The following table represents the estimated future amortization expense of intangible assets as of December 28, 2019:
|
| | | | |
| | Amount |
Fiscal Year | | (in thousands) |
Remainder of 2020 | | $ | 7,733 |
|
2021 | | 13,767 |
|
2022 | | 8,088 |
|
2023 | | 7,604 |
|
2024 | | 4,628 |
|
Thereafter | | 6,689 |
|
Total intangible assets | | $ | 48,509 |
|
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Maxim Integrated Products, Inc. (“Maxim Integrated” or the “Company” and also referred to as “we,” “our” or “us”) disclaims any duty to and undertakes no obligation to update any forward-looking statement, whether as a result of new information relating to existing conditions, future events or otherwise or to release publicly the results of any future revisions it may make to forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by federal securities laws. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date of this Quarterly Report on Form 10-Q. Readers should carefully review future reports and documents that the Company files with or furnishes to the SEC from time to time, such as its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, and any Current Reports on Form 8-K.
Overview of Business
Maxim Integrated Products, Inc. (“Maxim Integrated” or the “Company” and also referred to as “we,” “our” or “us”) designs, develops, manufactures and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of customers in diverse geographical locations. The analog market is fragmented and characterized by many diverse applications, a great number of product variations and, with respect to many circuit types, relatively long product life cycles. We are a global company with a wafer manufacturing facility in the U.S., test facilities in the Philippines and Thailand, and sales and circuit design offices around the world. We also utilize third parties for manufacturing and assembly of our products.
The Linear and Mixed-Signal Analog Integrated Circuit Market
All electronic signals generally fall into one of two categories, linear or digital. Linear (or analog) signals represent real world phenomena, such as temperature, pressure, sound or speed, and are continuously variable over a wide range of values. Digital signals represent the “ones” and “zeros” of binary arithmetic and are either on or off.
Three general classes of semiconductor products arise from this distinction between linear and digital signals:
| |
• | digital devices, such as memories and microprocessors that operate primarily in the digital domain; |
| |
• | linear devices, such as amplifiers, references, analog multiplexers and switches that operate primarily in the analog domain; and |
| |
• | mixed-signal devices such as data converter devices that combine linear and digital functions on the same integrated circuit and interface between the analog and digital domains. |
Our strategy has been to target both the linear and mixed-signal markets, often collectively referred to as the analog market. However, some of our products are exclusively or principally digital. While our focus continues to be on the linear and mixed-signal market, our capabilities in the digital domain enable development of new mixed-signal and other products with highly sophisticated digital characteristics.
At the beginning of fiscal year 2020, we combined our Computing Major End-Market category with our Communications and Data Center Major End-Market category. Our former Computing Major End-Market category focused on Desktop Computers, Notebook Computers, and Peripherals and Other Computer markets.
Our linear and mixed-signal products now serve four major end-markets: (i) Automotive, (ii) Communications and Data Center, (iii) Consumer and (iv) Industrial. These major end-markets and their corresponding markets are noted in the table below:
|
| | | |
MAJOR END-MARKET | | MARKET | |
| | | |
AUTOMOTIVE | Infotainment | |
| Powertrain | |
| Body Electronics | |
| Safety and Security | |
| | |
COMMUNICATIONS & DATA CENTER | Base Stations | |
| Data Center | |
| Data Storage | |
| Desktop Computers | |
| Network & Datacom | |
| Notebook Computers | |
| Peripherals & Other Computer | |
| Server | |
| Telecom | |
| Other Communications | |
| | |
CONSUMER | Smartphones | |
| Digital Cameras | |
| Handheld Computers | |
| Home Entertainment & Appliances | |
| Wearables | |
| Other Consumer | |
| | |
INDUSTRIAL | Automatic Test Equipment | |
| Control & Automation | |
| Electrical Instrumentation | |
| Financial Terminals | |
| Medical | |
| Security | |
| USB Extension | |
| Other Industrial | |
CRITICAL ACCOUNTING POLICIES
The methods, estimates, and judgments we use in applying our most critical accounting policies have a significant impact on the results we report in our financial statements. The Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as the ones that are most important to the presentation of our financial condition and results of operations, and that require us to make our most difficult and subjective accounting judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, our most critical accounting policies include revenue recognition, which impacts the recording of net revenues; valuation of inventories, which impacts costs of goods sold and gross margins; the assessment of recoverability of long-lived assets, which impacts impairment of long-lived assets; assessment of recoverability of intangible assets and goodwill, which impacts impairment of goodwill and intangible assets; accounting for income taxes, which impacts the income tax provision; and assessment of litigation and contingencies, which impacts charges recorded in cost of goods
sold, selling, general and administrative expenses and income taxes. These policies and the estimates and judgments involved are discussed further in the Management’s Discussion and Analysis of Financial Condition in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019. We have other significant accounting policies that either do not generally require estimates and judgments that are as difficult or subjective, or it is less likely that such accounting policies would have a material impact on our reported results of operations for a given period.
Except for the accounting policies and estimates outlined under Part I, Item 1. Financial Statements - Note 2, there have been no material changes during the six months ended December 28, 2019 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019.
RESULTS OF OPERATIONS
The following table sets forth certain Condensed Consolidated Statements of Income data expressed as a percentage of net revenues for the periods indicated:
|
| | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| December 28, 2019 | | December 29, 2018 | | December 28, 2019 | | December 29, 2018 |
| | | | | | | |
Net revenues | 100.0 | % | | 100.0 | % | | 100.0 | % | | 100.0 | % |
Cost of goods sold | 34.6 | % | | 35.3 | % | | 35.1 | % | | 33.9 | % |
Gross margin | 65.4 | % | | 64.7 | % | | 64.9 | % | | 66.1 | % |
Operating expenses: | | | | | | | |
Research and development | 20.3 | % | | 19.1 | % | | 20.4 | % | | 18.3 | % |
Selling, general and administrative | 13.8 | % | | 13.5 | % | | 14.0 | % | | 13.1 | % |
Intangible asset amortization | 0.1 | % | | 0.1 | % | | 0.1 | % | | 0.1 | % |
Impairment of long-lived assets | — | % | | 0.1 | % | | — | % | | 0.1 | % |
Severance and restructuring expenses | 0.5 | % | | 0.2 | % | | 0.4 | % | | 0.2 | % |
Other operating expenses (income), net | — | % | | — | % | | — | % | | — | % |
Total operating expenses | 34.7 | % | | 33.1 | % | | 34.9 | % | | 31.8 | % |
Operating income | 30.7 | % | | 31.6 | % | | 30.0 | % | | 34.3 | % |
Interest and other income (expense), net | — | % | | 0.1 | % | | 0.2 | % | | — | % |
Income before provision for income taxes | 30.7 | % | | 31.7 | % | | 30.2 | % | | 34.3 | % |
Income tax provision (benefit) | 4.2 | % | | 8.8 | % | | 3.8 | % | | 7.2 | % |
Net income | 26.5 | % | | 22.9 | % | | 26.4 | % | | 27.1 | % |
The following table shows stock-based compensation included in the components of the Condensed Consolidated Statements of Income reported above as a percentage of net revenues for the periods indicated:
|
| | | | | | | | | | | |
| Three Months Ended | | Six Months Ended |
| December 28, 2019 | | December 29, 2018 | | December 28, 2019 | | December 29, 2018 |
Cost of goods sold | 0.5 | % | | 0.4 | % | | 0.5 | % | | 0.4 | % |
Research and development | 2.1 | % | | 1.7 | % | | 2.1 | % | | 1.6 | % |
Selling, general and administrative | 1.8 | % | | 1.6 | % | | 1.9 | % | | 1.5 | % |
| 4.4 | % | | 3.7 | % | | 4.5 | % | | 3.5 | % |
Net Revenues
Net revenues were $551.1 million and $576.9 million for the three months ended December 28, 2019 and December 29, 2018, respectively. Revenue from consumer products was down by 22% primarily due to lower demand in smartphone products. Revenue from communications and data center products was up by 12% driven by an increased demand for base station, data center, and data storage products. These results include net revenues for the three months ended December 29, 2018 that align with our revised end-market categories.
Net revenues were $1.1 billion and $1.2 billion for the six months ended December 28, 2019 and December 29, 2018, respectively. Revenue from consumer products was down by 21% primarily due to lower demand in smartphone products. Revenue from industrial products was down by 11% primarily due to lower demand in control and automation products. These results include net revenues for the six months ended December 29, 2018 that align with our revised end-market categories.
During each of the three months ended December 28, 2019 and December 29, 2018, approximately 89% of net revenues, were derived from customers outside of the United States. While less than 1.0% of our sales are denominated in currencies other than U.S. dollars, we enter into foreign currency forward contracts to mitigate our risks on firm commitments and net monetary assets
denominated in foreign currencies. The impact of changes in foreign exchange rates on our revenue and results of operations for the three and six months ended December 28, 2019 and December 29, 2018 was immaterial.
Gross Margin
Our gross margin percentages were 65.4% and 64.7% for the three months ended December 28, 2019 and December 29, 2018, respectively. Our gross margin increased by 0.7 percentage points, primarily due to lower inventory reserve requirements.
Our gross margin percentages were 64.9% and 66.1% for the six months ended December 28, 2019 and December 29, 2018, respectively. Our gross margin decreased by 1.2 percentage points, primarily due to lower revenues.
Research and Development
Research and development expenses were $111.9 million and $110.3 million for the three months ended December 28, 2019 and December 29, 2018, respectively, which represented 20.3% and 19.1% of net revenues for each respective period. The $1.6 million increase was due to higher salaries and related personnel costs.
Research and development expenses were $220.9 million and $223.0 million for the six months ended December 28, 2019 and December 29, 2018, respectively, which represented 20.4% and 18.3% of net revenues for each respective period. The $2.1 million decrease was due to lower salaries and travel expenses.
Selling, General and Administrative
Selling, general and administrative expenses were $76.1 million and $77.9 million for the three months ended December 28, 2019 and December 29, 2018, respectively, which represented 13.8% and 13.5% of net revenues for each respective period. The $1.8 million decrease was due to lower travel and marketing expenses.
Selling, general and administrative expenses were $152.2 million and $159.4 million for the six months ended December 28, 2019 and December 29, 2018, respectively, which represented 14.0% and 13.1% of net revenues for each respective period. The $7.2 million decrease was due to lower salaries and related personnel costs, and lower depreciation and travel expenses.
Provision for Income Taxes
In the three and six months ended December 28, 2019, the Company recorded an income tax provision of $23.0 million and $40.7 million, respectively, compared to $50.8 million and $87.0 million for the three and six months ended December 29, 2018, respectively. The Company’s effective tax rate for the three and six months ended December 28, 2019 was 13.6% and 12.4%, respectively, compared to 27.8% and 20.9% for the three and six months ended December 29, 2018, respectively.
On December 22, 2017, legislation, commonly referred to as the Tax Cuts and Jobs Act (the “Act”), was enacted. The Act included a one-time tax on accumulated unremitted earnings of the Company's foreign subsidiaries (“Transition Tax”). SEC Staff Accounting Bulletin No. 118 allowed the use of provisional amounts (reasonable estimates) if accounting for the income tax effects of the Act was not completed. Provisional amounts must be adjusted within a one-year measurement period from the enactment date of the Act. In the second quarter of fiscal year 2018, the Company recorded a discrete $236.9 million provisional Transition Tax charge. During the measurement period, the Company gathered additional information and analyzed available guidance to more precisely compute the amount of the Transition Tax. In the second quarter of fiscal year 2019 the Company completed this work and recorded a discrete $22.1 million measurement period adjustment for the Transition Tax, which increased the Company’s effective tax rate for the three and six months ended December 29, 2018 by 12.1% and 5.3%, respectively. As of the end of the second quarter of fiscal year 2019, the accounting for income tax effects of the Act was completed.
The Company’s federal statutory tax rate is 21%. The Company’s effective tax rate for the three and six months ended December 28, 2019 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by U.S. tax expense related to Global Intangible Low-Taxed Income (“GILTI”).
The Company’s effective tax rate for the three months ended December 29, 2018 was higher than the statutory rate primarily due to a $22.1 million discrete charge for the Transition Tax, U.S. tax expense related to GILTI, and a $4.9 million discrete charge for interest accruals for unrecognized tax benefits, partially offset by earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates.
The Company’s effective tax rate for the six months ended December 29, 2018 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by a $22.1 million discrete charge for the Transition Tax, U.S. tax expense related to GILTI, and a $9.4 million discrete charge for interest accruals for unrecognized tax benefits.
BACKLOG
As of December 28, 2019 and June 29, 2019, our current quarter backlog was approximately $455.6 million and $391.3 million respectively. In backlog, we include orders with customer request dates within the next three months. As is customary in the semiconductor industry, these orders may be canceled in most cases without penalty to customers. Accordingly, we believe that our backlog is not a reliable measure of future revenues. All backlog numbers have been adjusted for estimated future distribution ship and debit pricing adjustments.
FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
Financial Condition
Cash flows were as follows:
|
| | | | | | | |
| Six Months Ended |
| December 28, 2019 | | December 29, 2018 |
| (in thousands) |
Net cash provided by (used in) operating activities | $ | 378,735 |
| | $ | 431,435 |
|
Net cash provided by (used in) investing activities | 43,869 |
| | 496,454 |
|
Net cash provided by (used in) financing activities | (459,752 | ) | | (1,064,633 | ) |
Net increase (decrease) in cash and cash equivalents | $ | (37,148 | ) | | $ | (136,744 | ) |
Operating activities
Cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities.
Cash provided by operating activities decreased by $52.7 million for the six months ended December 28, 2019 compared with the six months ended December 29, 2018 due mainly to lower net income and changes in working capital. Changes in working capital were driven by changes in income tax payable, partially offset by changes in accrued expenses and inventories.
Investing activities
Investing cash flows consist primarily of net investment purchases and maturities, and capital expenditures.
Cash provided by investing activities decreased by $452.6 million for the six months ended December 28, 2019 compared with the six months ended December 29, 2018. The decrease was due to lower proceeds from maturity of available-for-sale securities offset by lower purchases of available-for-sale securities.
Financing activities
Financing cash flows consist primarily of debt issuance, repurchases of common stock, and payment of dividends to stockholders.
Cash used in financing activities decreased by $604.9 million for the six months ended December 28, 2019 compared with the six months ended December 29, 2018. The decrease was due to a $500.0 million debt repayment we made in November 2018 and lower repurchases of common stock.
Liquidity and Capital Resources
Our primary source of liquidity is our cash flows from operating activities resulting from net income and management of working capital.
As of December 28, 2019, our available funds consisted of $1.8 billion in cash, cash equivalents and short-term investments.
On October 30, 2018, we were authorized to repurchase up to $1.5 billion of the Company's common stock. During the three and six months ended December 28, 2019, we repurchased an aggregate of $108.0 million and $201.5 million of the Company's common stock, respectively.
During the three and six months ended December 28, 2019, we paid cash dividends of $0.48 and $0.96 per common share totaling $129.8 million and $260.0 million, respectively.
We anticipate that the available funds and cash generated from operations will be sufficient to meet cash and working capital requirements, including the anticipated level of capital expenditures, common stock repurchases, debt repayments and dividend payments for at least the next twelve months.
Off-Balance-Sheet Arrangements
As of December 28, 2019, we did not have any material off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.
ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company’s market risk has not changed materially from the interest rate and foreign currency risks disclosed in Item 7A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 29, 2019.
The impact of inflation and changing prices on the Company’s net revenues and on operating income during the three and six months ended December 28, 2019 and December 29, 2018 was not material.
ITEM 4: CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our chief executive officer (“CEO”) and our chief financial officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of December 28, 2019. Our management, including the CEO and the CFO, has concluded that the Company’s disclosure controls and procedures were effective as of December 28, 2019. The purpose of these controls and procedures is to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules, and that such information is accumulated and communicated to our management, including our CEO and our CFO, to allow timely decisions regarding required disclosures.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended December 28, 2019 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
Inherent Limitations on the Effectiveness of Internal Controls
A system of internal control over financial reporting is intended to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements in accordance with GAAP, and no control system, no matter how well designed and operated, can provide absolute assurance. The design of any control system is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of its inherent limitations, internal control over financial reporting may not prevent or detect financial statement errors and misstatements. Also, projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.
PART II. OTHER INFORMATION
ITEM 1: LEGAL PROCEEDINGS
The information set forth above under Part I, Item 1, Note 11 “Commitments and Contingencies” to the Condensed Consolidated Financial Statements is incorporated herein by reference.
ITEM 1A: RISK FACTORS
A description of risks associated with our business, financial condition and results of our operations is set forth in Item 1A - Risk Factors of our Annual Report on Form 10-K for the fiscal year ended June 29, 2019, which is incorporated herein by reference.
ITEM 2: UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On October 30, 2018, the Board of Directors of the Company authorized the repurchase of up to $1.5 billion of the Company’s common stock. This stock repurchase authorization does not have an expiration date and the pace of repurchase activity will depend on factors such as current stock price, levels of cash generated from operations, cash requirements, and other factors. The Company’s prior repurchase authorization was cancelled and superseded by this new repurchase authorization.
The following table summarizes the activity related to stock repurchases for the three months ended December 28, 2019:
|
| | | | | | | | | | | | | |
| Issuer Repurchases of Equity Securities |
| (in thousands, except per share amounts) |
| Total Number of Shares Purchased | | Average Price Paid per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs |
Sep 29, 2019 - Oct 26, 2019 | 515 |
| | $ | 57.45 |
| | 515 |
| | $ | 991,836 |
|
Oct 27, 2019 - Nov 23, 2019 | 520 |
| | 58.29 |
| | 520 |
| | 961,551 |
|
Nov 24, 2019 - Dec 28, 2019 | 827 |
| | 58.14 |
| | 827 |
| | 913,473 |
|
Total for the quarter | 1,862 |
| | $ | 57.99 |
| | 1,862 |
| | $ | 913,473 |
|
In the three months ended December 28, 2019, the Company repurchased approximately 1.9 million shares of its common stock for approximately $108.0 million. As of December 28, 2019, the Company had remaining authorization of $0.9 billion for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.
ITEM 3: DEFAULTS UPON SENIOR SECURITIES
Not applicable.
ITEM 4: MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5: OTHER INFORMATION
None.
ITEM 6: EXHIBITS
(a) Exhibits
|
| |
| |
| |
| |
| |
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. (1) |
101.SCH | Inline XBRL Taxonomy Extension Schema Document (1) |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (1) |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (1) |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (1) |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (1) |
104 | Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. (1) |
|
| | | | |
(1) Filed or furnished herewith. |
In accordance with Rule 406T of Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| | |
January 29, 2020 | | MAXIM INTEGRATED PRODUCTS, INC. |
| | |
| | By:/s/ Brian C. White |
| | Brian C. White |
| | Senior Vice President, Chief Financial Officer |